Literature DB >> 20150212

Increasing incidence of community-associated atypical Clostridium difficile disease in children.

Susan S Baker1, Howard Faden, Wael Sayej, Raza Patel, Robert D Baker.   

Abstract

Forty-one children with a variety of gastrointestinal complaints were diagnosed with Clostridium difficile infections as part of a routine screen over 3 years. The infection had not been suspected prior to the screen. Each child responded to treatment with metronidazole with resolution of their symptoms. These data suggest that community-associated C difficile is increasing and may produce atypical disease and lead to misdiagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150212     DOI: 10.1177/0009922809360927

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  10 in total

1.  Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital.

Authors:  Ruth Ann Luna; Bobby L Boyanton; Seema Mehta; Ebony M Courtney; C Renee Webb; Paula A Revell; James Versalovic
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

2.  Delirium and other clinical factors with Clostridium difficile infection that predict mortality in hospitalized patients.

Authors:  Laurie R Archbald-Pannone; Timothy L McMurry; Richard L Guerrant; Cirle A Warren
Journal:  Am J Infect Control       Date:  2015-04-24       Impact factor: 2.918

3.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

4.  Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.

Authors:  Julia Shaklee Sammons; Russell Localio; Rui Xiao; Susan E Coffin; Theoklis Zaoutis
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

5.  The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.

Authors:  Glen P Carter; Gillian R Douce; Revathi Govind; Pauline M Howarth; Kate E Mackin; Janice Spencer; Anthony M Buckley; Ana Antunes; Despina Kotsanas; Grant A Jenkin; Bruno Dupuy; Julian I Rood; Dena Lyras
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

6.  A New Lab Developed Real Time PCR Assay for Direct Detection of C. Difficle from Stool Sample without DNA Extraction.

Authors:  Brandon Li
Journal:  Int J Biomed Sci       Date:  2016-09

7.  Risk factors for community-associated Clostridioides difficile infection in young children.

Authors:  M K Weng; S H Adkins; W Bamberg; M M Farley; C C Espinosa; L Wilson; R Perlmutter; S Holzbauer; T Whitten; E C Phipps; E B Hancock; G Dumyati; D S Nelson; Z G Beldavs; V Ocampo; C M Davis; B Rue; L Korhonen; L C McDonald; A Y Guh
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 8.  Community-acquired Clostridium difficile infection: an increasing public health threat.

Authors:  Arjun Gupta; Sahil Khanna
Journal:  Infect Drug Resist       Date:  2014-03-17       Impact factor: 4.003

9.  Clostridium difficile infection in children hospitalized due to diarrhea.

Authors:  K Dulęba; M Pawłowska; M Wietlicka-Piszcz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-10       Impact factor: 3.267

Review 10.  Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance.

Authors:  Priscilla A Johanesen; Kate E Mackin; Melanie L Hutton; Milena M Awad; Sarah Larcombe; Jacob M Amy; Dena Lyras
Journal:  Genes (Basel)       Date:  2015-12-21       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.